Anzeige
Mehr »
Login
Sonntag, 11.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Kurseskalation am Montag? Diese Gamechanger-News macht es möglich!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 897518 ISIN: US62855J1043 Ticker-Symbol: MYD 
Tradegate
09.04.21
20:53 Uhr
23,600 Euro
-0,300
-1,26 %
1-Jahres-Chart
MYRIAD GENETICS INC Chart 1 Jahr
5-Tage-Chart
MYRIAD GENETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
23,47023,96010.04.
23,49023,79009.04.

Aktuelle News zur MYRIAD GENETICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MYRIAD GENETICS Aktie jetzt für 0€ handeln
29.03.Myriad Genetics' (MYGN) myChoice Gets Additional Reimbursement2
29.03.Myriad Genetics, Inc.: Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders1
24.03.Myriad Genetics, Inc.: Myriad Genetics Receives Additional Reimbursement for myChoice Diagnostic System in Japan3
16.03.MYRIAD GENETICS INC - S-8, Securities to be offered to employees in employee benefit plans2
05.03.Myriad Genetics (MYGN) Collaborates to Advance Oncology Care3
02.03.Myriad Genetics files to delay 10-K submission4
02.03.MYRIAD GENETICS INC - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4052
02.03.Myriad Genetics, Inc.: Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing ...2
24.02.Myriad Genetics (MYGN) Beats on Q2 Revenues, Earnings in Line3
24.02.Myriad Genetics, Inc. (MYGN) CEO Paul Diaz on Q2 2021 Results - Earnings Call Transcript2
23.02.Myriad Genetics Inc. Q4 adjusted earnings Inline With Estimates335WASHINGTON (dpa-AFX) - Below are the earnings highlights for Myriad Genetics Inc. (MYGN):-Earnings: -$44.2 million in Q4 vs. -$8.3 million in the same period last year. -EPS: -$0.59 in Q4...
► Artikel lesen
23.02.MYRIAD GENETICS INC - 8-K, Current Report2
23.02.Myriad Genetics, Inc.: Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan1
18.02.Myriad Genetics, Inc.: Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and ...6
16.02.Myriad Genetics, Inc.: Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 20213
15.02.Myriad Genetics' (MYGN) Prolaris Test Study Outcome Favorable5
12.02.Myriad Genetics announces new data to validate Prolaris test for prostate cancer3
12.02.Myriad Genetics, Inc.: New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics' Prolaris test to Guide Treatment ...1
10.02.New Study Favors Myriad Genetics' (MYGN) GeneSight Test2
08.02.Myriad Genetics Q4 2021 Earnings Preview9
Seite:  Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1